510(k) Report

PMA · Approved

Recalled · Class II · 2025

Lumicell Direct Visualization System (DVS)

P230014PMAApproved Apr 17, 2024369-day reviewClass IIIRecalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Lumicell, Inc. · SAW Fluorescence Imaging For Breast Cancer Detection

Approved on Apr 17, 2024 through premarket approval, which rests on the device’s own clinical evidence after a 369-day review. It has been recalled once.

Decided
Apr 17, 2024
Review
369 days
Class
Class III
Product code
SAW
Recalls
1

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P230014 has 4 supplements since 2024: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2024: 22025: 2
2024high 2 (2024)2025
View FIG. 1 as a table
YearSupplements approved
20242
20252
FIG. 1 — Supplements to P230014, 2024–2025Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in SAW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 31, 2025Class IIZ-2519-2025Under Investigation by firmThe potential of the elastic bands included in the kit detaching or fracturing during surgical procedures. As a result, these failures may pose a risk of retained foreign bodies in the surgical cavity and potentially leading to surgical…

No ancestor or descendant has a Class I recall.

How does its category compare?

All SAW devices

SAW Fluorescence Imaging For Breast Cancer Detection: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · SAW

2in 2025

2024: 32025: 2
2007high 3 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · SAW

Too few SAW 510(k)s in any year since 2007 to give a median.

Recalls per year · SAW

No recall names SAW since 2007.

Adverse event reports per year · SAW

No MAUDE report names SAW since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20243—00
20252—00
20260—0—
Cite this page

510(k) Report. “P230014: Lumicell Direct Visualization System (DVS).” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P230014

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026